CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,821,000 | +106.2% | 73,965 | -1.1% | 0.01% | +100.0% |
| Q2 2022 | $1,853,000 | +13.9% | 74,776 | +15.2% | 0.00% | +50.0% |
| Q1 2022 | $1,627,000 | -36.8% | 64,905 | -8.2% | 0.00% | -33.3% |
| Q4 2021 | $2,575,000 | +117.9% | 70,725 | +2.4% | 0.00% | +50.0% |
| Q3 2021 | $1,182,000 | +12.1% | 69,097 | -12.2% | 0.00% | +100.0% |
| Q2 2021 | $1,054,000 | -74.0% | 78,694 | -0.4% | 0.00% | -80.0% |
| Q1 2021 | $4,050,000 | -17.5% | 79,040 | -0.3% | 0.01% | -28.6% |
| Q4 2020 | $4,907,000 | +12.9% | 79,251 | -0.0% | 0.01% | 0.0% |
| Q3 2020 | $4,345,000 | +12.6% | 79,282 | +18.2% | 0.01% | 0.0% |
| Q2 2020 | $3,859,000 | +55.1% | 67,060 | +8.3% | 0.01% | +40.0% |
| Q1 2020 | $2,488,000 | +1.1% | 61,923 | -0.5% | 0.01% | +25.0% |
| Q4 2019 | $2,461,000 | +479.1% | 62,230 | -0.8% | 0.00% | +300.0% |
| Q3 2019 | $425,000 | -27.1% | 62,729 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $583,000 | +19.0% | 62,729 | +78.0% | 0.00% | 0.0% |
| Q1 2019 | $490,000 | +27.3% | 35,245 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $385,000 | -11.5% | 35,245 | +2.5% | 0.00% | 0.0% |
| Q3 2018 | $435,000 | -1.6% | 34,380 | +2.5% | 0.00% | 0.0% |
| Q2 2018 | $442,000 | -14.8% | 33,543 | -12.2% | 0.00% | 0.0% |
| Q1 2018 | $519,000 | +123.7% | 38,188 | -2.0% | 0.00% | – |
| Q4 2017 | $232,000 | -18.0% | 38,951 | +2.3% | 0.00% | -100.0% |
| Q3 2017 | $283,000 | -30.1% | 38,082 | -11.9% | 0.00% | 0.0% |
| Q2 2017 | $405,000 | +20.2% | 43,240 | -6.5% | 0.00% | 0.0% |
| Q1 2017 | $337,000 | -3.7% | 46,240 | -2.3% | 0.00% | 0.0% |
| Q4 2016 | $350,000 | +19.5% | 47,340 | -2.3% | 0.00% | 0.0% |
| Q3 2016 | $293,000 | +45.8% | 48,440 | +8.3% | 0.00% | – |
| Q2 2016 | $201,000 | +34.9% | 44,740 | -25.1% | 0.00% | – |
| Q1 2016 | $149,000 | -64.5% | 59,746 | +15.2% | 0.00% | -100.0% |
| Q4 2015 | $420,000 | +36.4% | 51,873 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $308,000 | -26.7% | 50,889 | -0.4% | 0.00% | 0.0% |
| Q2 2015 | $420,000 | +10.2% | 51,089 | +1.2% | 0.00% | 0.0% |
| Q1 2015 | $381,000 | +10.4% | 50,465 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $345,000 | +52.7% | 50,465 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $226,000 | -22.6% | 50,249 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $292,000 | -0.3% | 49,962 | +13.1% | 0.00% | 0.0% |
| Q1 2014 | $293,000 | +14.5% | 44,162 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $256,000 | +4.1% | 44,162 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $246,000 | -59.4% | 44,162 | +3.1% | 0.00% | -50.0% |
| Q2 2013 | $606,000 | +366.2% | 42,838 | +353.9% | 0.00% | – |
| Q1 2013 | $130,000 | – | 9,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |